Pinnacle Associates’s Prestige Consumer Healthcare PBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.13M Buy
23,957
+1,250
+6% +$64.2K 0.01% 507
2026
Q1
$1.35M Buy
22,707
+2,710
+14% +$176K 0.02% 466
2025
Q4
$1.23M Buy
19,997
+7,427
+59% +$455K 0.02% 483
2025
Q3
$784K Sell
12,570
-683
-5% -$47.5K 0.01% 551
2025
Q2
$1.06M Sell
13,253
-214
-2% -$17.9K 0.02% 492
2025
Q1
$1.16M Sell
13,467
-600
-4% -$49.2K 0.02% 469
2024
Q4
$1.1M Sell
14,067
-10,563
-43% -$820K 0.01% 470
2024
Q3
$1.51M Buy
24,630
+9,269
+60% +$656K 0.03% 397
2024
Q2
$1.06M Sell
15,361
-159
-1% -$10.8K 0.02% 458
2024
Q1
$1.13M Sell
15,520
-9,110
-37% -$609K 0.02% 463
2023
Q4
$1.51M Sell
24,630
-42
-0.2% -$2.49K 0.03% 402
2023
Q3
$1.41M Buy
24,672
+200
+0.8% +$12.1K 0.03% 404
2023
Q2
$1.45M Buy
+24,472
New +$1.46M 0.03% 404

Other funds holding PBH

Pinnacle Associates's PBH Position: Q2 2026 in Review

Pinnacle Associates increased its Prestige Consumer Healthcare (PBH) stake by 5.5% in Q2 2026, buying an estimated $64.2K and bringing the position to 23,957 shares worth $1.13M. The position accounts for 0.01% of the portfolio, ranked #507.

Pinnacle Associates first reported a position in PBH in Q2 2023 and has held it in 13 quarters since. The position peaked at $1.51M in Q3 2024. 319 funds tracked by Wall St. Rank hold PBH as of Q2 2026.

  • Pinnacle Associates held 23,957 shares of Prestige Consumer Healthcare worth $1.13M as of Q2 2026.
  • Pinnacle Associates bought 1,250 Prestige Consumer Healthcare shares in Q2 2026, an estimated $64.2K.
  • Prestige Consumer Healthcare made up 0.01% of Pinnacle Associates's portfolio in Q2 2026, its #507 holding.
  • Pinnacle Associates first reported a position in Prestige Consumer Healthcare in Q2 2023 and has held it in 13 quarters since.
  • Pinnacle Associates's Prestige Consumer Healthcare position peaked at $1.51M in Q3 2024.
  • 319 funds tracked by Wall St. Rank held Prestige Consumer Healthcare as of Q2 2026.

Based on Pinnacle Associates's 13F filing for Q2 2026, filed 3 Aug 2026.